[go: up one dir, main page]

DE69535428D1 - Verfahren zum Auffinden von differentiel exprimierte Gene - Google Patents

Verfahren zum Auffinden von differentiel exprimierte Gene

Info

Publication number
DE69535428D1
DE69535428D1 DE69535428T DE69535428T DE69535428D1 DE 69535428 D1 DE69535428 D1 DE 69535428D1 DE 69535428 T DE69535428 T DE 69535428T DE 69535428 T DE69535428 T DE 69535428T DE 69535428 D1 DE69535428 D1 DE 69535428D1
Authority
DE
Germany
Prior art keywords
differentially expressed
expressed genes
finding
finding differentially
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535428T
Other languages
English (en)
Other versions
DE69535428T2 (de
Inventor
Martin Rosenberg
Christine Debouck
Derk Bergsma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69535428D1 publication Critical patent/DE69535428D1/de
Publication of DE69535428T2 publication Critical patent/DE69535428T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE1995635428 1994-02-14 1995-02-14 Verfahren zum Auffinden von differentiel exprimierte Gene Expired - Lifetime DE69535428T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19548594A 1994-02-14 1994-02-14
US195485 1994-02-14
PCT/US1995/001863 WO1995021944A1 (en) 1994-02-14 1995-02-14 Differentially expressed genes in healthy and diseased subjects

Publications (2)

Publication Number Publication Date
DE69535428D1 true DE69535428D1 (de) 2007-05-03
DE69535428T2 DE69535428T2 (de) 2007-12-06

Family

ID=22721588

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1995635428 Expired - Lifetime DE69535428T2 (de) 1994-02-14 1995-02-14 Verfahren zum Auffinden von differentiel exprimierte Gene

Country Status (4)

Country Link
EP (2) EP1813684A3 (de)
JP (1) JPH09508800A (de)
DE (1) DE69535428T2 (de)
WO (1) WO1995021944A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US7323298B1 (en) 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US6418382B2 (en) 1995-10-24 2002-07-09 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5972693A (en) * 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
EP0880598A4 (de) 1996-01-23 2005-02-23 Affymetrix Inc Verfahren zur analyse von nukleinsäure
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6228589B1 (en) 1996-10-11 2001-05-08 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5928871A (en) * 1996-11-18 1999-07-27 The Rockefeller University CDNA collections encoding proteins regulated during programmed cell death, and method of use thereof
WO1998051824A1 (en) * 1997-05-15 1998-11-19 Abbott Laboratories Reagents and methods useful for detecting disease of the urinary tract
US6890749B2 (en) 1997-05-15 2005-05-10 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US6333152B1 (en) 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells
US6489455B2 (en) 1997-05-21 2002-12-03 Clontech Laboratories, Inc. Methods of assaying differential expression
JP2001522249A (ja) * 1997-06-05 2001-11-13 アボツト・ラボラトリーズ 尿路の疾患の検出に有用な試薬および方法
WO1999002734A1 (en) * 1997-07-08 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
EP1042504A2 (de) * 1997-12-29 2000-10-11 Genena Ltd. Verfahren zur erkennung und charakterisierung von zellen und gewebe
US6265163B1 (en) 1998-01-09 2001-07-24 Lynx Therapeutics, Inc. Solid phase selection of differentially expressed genes
WO2000055323A1 (en) * 1999-03-16 2000-09-21 Mitokor Differential expression of organellar gene products
WO2000065091A2 (en) * 1999-04-23 2000-11-02 Curagen Corporation Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression
US7122303B2 (en) 1999-09-17 2006-10-17 Agilent Technologies, Inc. Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same
US7078167B2 (en) 1999-09-17 2006-07-18 Agilent Technologies, Inc. Arrays having background features and methods for using the same
WO2001044512A2 (en) * 1999-12-16 2001-06-21 Curagen Corporation Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression
US6413722B1 (en) 2000-03-22 2002-07-02 Incyte Genomics, Inc. Polymer coated surfaces for microarray applications
US7666586B2 (en) 2000-06-30 2010-02-23 Aros Applied Biotechnology Aps Gene expression in biological conditions
US6900013B1 (en) 2000-08-25 2005-05-31 Aviva Biosciences Corporation Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
EP1623010A4 (de) 2003-04-25 2007-12-26 Janssen Pharmaceutica Nv Konservierung von rna in einer biologischen probe
EP2471921A1 (de) 2004-05-28 2012-07-04 Asuragen, Inc. Verfahren und Zusammensetzungen mit microRNA
JP2008519606A (ja) 2004-11-12 2008-06-12 アンビオン インコーポレーティッド miRNAおよびmiRNA阻害分子に関する方法および組成物
CN101384733A (zh) 2006-02-13 2009-03-11 奥尔加·奥尔纳茨基 通过元素分析实施的基因表达检测
JP5520605B2 (ja) 2006-09-19 2014-06-11 アシュラジェン インコーポレイテッド 膵臓疾患で差次的に発現されるマイクロrnaおよびその使用
WO2008036776A2 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
CA2723984A1 (en) 2008-05-14 2009-11-19 Genomic Health Inc. Predictors of patient response to treatment with egf receptor inhibitors
EP3214174B1 (de) 2010-03-04 2019-10-16 InteRNA Technologies B.V. Mirna-molekül, das über seine quelle definiert ist, und seine diagnostischen und therapeutischen verwendungen bei mit emt assoziierten krankheiten
EP2566973A4 (de) 2010-05-04 2013-11-27 Medimmune Llc Optimierte diagnose und behandlung von muskelabbauerkrankungen
US9133524B2 (en) 2010-07-01 2015-09-15 The Regents Of The University Of California Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use
NZ704322A (en) 2010-07-06 2016-07-29 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
CA2817882C (en) 2010-11-17 2022-08-23 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2474617A1 (de) 2011-01-11 2012-07-11 InteRNA Technologies BV MIR zur Behandlung von Neoangiogenese
EP2681566A2 (de) 2011-02-28 2014-01-08 University of Iowa Research Foundation Anti-müller-hormon-veränderungen in der schwangerschaft und vorhersage von schwangerschaftsnebenwirkungen und des geschlechts
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
WO2013063519A1 (en) 2011-10-26 2013-05-02 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
WO2013063544A1 (en) 2011-10-27 2013-05-02 Asuragen, Inc. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
EP2870263A1 (de) 2012-07-03 2015-05-13 InteRNA Technologies B.V. Diagnoseportfolio und dessen verwendungen
WO2014055117A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
WO2014151551A1 (en) 2013-03-15 2014-09-25 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
EP2970909A4 (de) 2013-03-15 2017-02-15 The University of Chicago Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität
EP2971132B1 (de) 2013-03-15 2020-05-06 Baylor Research Institute Gewebe- und blutbasierte mirna-biomarker zur diagnose, prognose und vorhersage des metastasepotenzials bei kolorektalkrebs
US10550440B2 (en) 2016-02-26 2020-02-04 Arizona Board Of Regents On Behalf Of Arizona State University Synthetic translation-sensing riboswitches and uses thereof
US11497762B2 (en) 2017-11-03 2022-11-15 Interna Technologies B.V. MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
WO2019104155A2 (en) 2017-11-22 2019-05-31 The University Of Chicago Chemical probe-dependent evaluation of protein activity and uses thereof
US20220162198A1 (en) 2019-04-12 2022-05-26 The Regents Of The University Of California Compositions and methods for increasing muscle mass and oxidative metabolism
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007087A1 (en) * 1989-11-13 1991-05-30 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
AU2240492A (en) * 1991-06-20 1993-01-25 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The Sequences characteristic of human gene transcription product
CA2089045A1 (en) * 1992-02-28 1993-08-29 Stephanie J. Lemke Differential screening protocol that allows the detection of marginally induced or repressed mrnas

Also Published As

Publication number Publication date
DE69535428T2 (de) 2007-12-06
EP1813684A3 (de) 2009-11-18
EP1813684A2 (de) 2007-08-01
JPH09508800A (ja) 1997-09-09
EP0743989A4 (de) 2000-11-08
WO1995021944A1 (en) 1995-08-17
EP0743989B1 (de) 2007-03-21
EP0743989A1 (de) 1996-11-27

Similar Documents

Publication Publication Date Title
DE69535428D1 (de) Verfahren zum Auffinden von differentiel exprimierte Gene
DE69520330D1 (de) Verfahren zum Nachweis von spezifischen Nukleinsäuresequenzen
EP1106061A4 (de) Verfahren zum verändern von chromosomen
FI972424A7 (fi) Menetelmä geenien identifioimiseksi
DE69125441D1 (de) Verfahren zum Gennachweis
DE69706430D1 (de) Verfahren zur sequenzierung von dna
DE59814043D1 (de) Verfahren zum anisotropen ätzen von silizium
DE69207580D1 (de) Verfahren zum DNS-Nachweis
DE69720465D1 (de) Verfahren zum wiedergewinnen von prozessflüssigkeiten
DE69508921D1 (de) Verfahren zum nachweis von staphylokokken
DE69827657D1 (de) Verfahren zum trennen von aromaten
DE69406357D1 (de) Verfahren zum Nitrocarbrineren von Stahl
DE69910466D1 (de) Verfahren zum Verfeinern von Deskriptoren
DE69731826D1 (de) Verfahren zum beschichten von substraten
DE69530277D1 (de) Verfahren zur auswahl von übertragungsvorzügen
DE69820814T2 (de) Verfahren zum Verbinden von metallischen Elementen
DE69715006D1 (de) Verfahren zur sequenzierung von nukleinsäuren
DE69628850D1 (de) Enzymatisches verfahren zum färben
DE69702016D1 (de) Verfahren zum Ersetzen von Datenblöcken
DE69624783D1 (de) Verfahren zum vakuumfeinen von stahlschmelze
DE69826458D1 (de) Verfahren zum sequenzierung von dna
DE69233253D1 (de) Verfahren zum Klonieren eines Pol-I-Typ DNS-Polymerase-Gens
DE69730979D1 (de) Verfahren zum entwerfen von luftreifen
DE59402040D1 (de) Verfahren zur Einfärbung von organischen Medien
DE69710299D1 (de) Verfahren zum Markieren von Reifen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SMITHKLINE BEECHAM CORP., PHILADELPHIA, PA., US

8364 No opposition during term of opposition